Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to compare if a single dose of oral etoricoxib 120 mg will have
equal post-operative analgesic efficacy as an optimal regiment of intravenous ketorolac 30 mg
+ 30 mg during the first 18 hours (+/- 1 hour) after gynaecologic laparoscopic surgical
procedures, where the need for post-operative opioid is expected.